斑块逆转与他汀类药物-课件.pptVIP

MASS—多中心抗动脉粥样硬化研究 * Slide 20. ARBITER 2: baseline therapies By study design, all participants of ARBITER 2 were already treated with statins, typically simvastatin (93% of patients) at a mean dose of approximately 35 mg/d. The participants also were commonly treated with medications typical of secondary prevention of CHD, including beta-blockers and aspirin in most. Antioxidant vitamins were discontinued to avoid interference with the effects of niacin on increasing apolipoprotein A-I concentrations. Additional abbreviation on slide: ACE = angiotensin-converting enzyme. References: Tay